Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease
NCT: NCT03871075 · ACTIVE_NOT_RECRUITING
Brief Summary
The INTERCEDE randomized trial will establish whether six-months of intermittent pneumatic compression combined with walking exercise improves walking endurance at six-month follow-up, compared to walking exercise + sham compression therapy, in people with lower extremity peripheral artery disease (PAD). The INTERCEDE trial will also determine whether intermittent pneumatic compression therapy improves walking endurance at 6-month follow-up, compared to a sham compression therapy. The trial will also determine whether benefits of intermittent pneumatic compression persist after intermittent pneumatic compression treatment is completed.
Frequently Asked Questions
What is Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease?
Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease is a clinical trial registered under NCT03871075. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT03871075?
The current status of NCT03871075 (Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease) is: ACTIVE_NOT_RECRUITING.
When did Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease start?
Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease started on 2019-01-02.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.